|
ZNF224 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.548300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.002200E-01 |
| Normal-vs-Stage2 |
3.412800E-01 |
| Normal-vs-Stage3 |
1.477370E-01 |
| Normal-vs-Stage4 |
2.941800E-01 |
| Stage1-vs-Stage2 |
8.087000E-01 |
| Stage1-vs-Stage3 |
2.763500E-03 |
| Stage1-vs-Stage4 |
1.610980E-01 |
| Stage2-vs-Stage3 |
9.904400E-02 |
| Stage2-vs-Stage4 |
2.244600E-01 |
| Stage3-vs-Stage4 |
9.969800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.900500E-02 |
| Normal-vs-AfricanAmerican |
1.467230E-01 |
| Normal-vs-Asian |
3.752000E-01 |
| Caucasian-vs-AfricanAmerican |
9.493000E-01 |
| Caucasian-vs-Asian |
6.830600E-01 |
| AfricanAmerican-vs-Asian |
7.166200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.032200E-02 |
| Normal-vs-Female |
5.539800E-02 |
| Male-vs-Female |
5.868600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.107600E-01 |
| Normal-vs-Extreme_Weight |
7.024200E-01 |
| Normal-vs-Obese |
2.596200E-02 |
| Normal-vs-Extreme_Obese |
7.231200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.933800E-01 |
| Normal_Weight-vs-Obese |
5.898400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.361200E-01 |
| Extreme_Weight-vs-Obese |
5.474100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.434600E-01 |
| Obese-vs-Extreme_Obese |
3.737600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.548200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.544800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.019000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.791200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.038600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.617600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.542960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.168100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.153800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.532600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.339030E-03 |
| Normal-VS-Type2 PRCC |
1.282830E-01 |
| Normal-VS-KIRP CIMP |
6.734600E-01 |
| Normal-VS-Unclassified PRCC |
1.215840E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.70809999769872E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.164810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.322600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.734600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.478400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.511400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.703800E-01 |
| Normal-vs-N1 |
6.216600E-01 |
| Normal-vs-N2 |
7.468400E-02 |
| N0-vs-N1 |
8.797000E-01 |
| N0-vs-N2 |
2.382400E-01 |
| N1-vs-N2 |
9.315800E-02 |
|
|
